ProAir Shortage Update: What Patients Need to Know in 2026

The albuterol shortage has been one of the most prolonged medication supply crises of recent years — and for good reason. Albuterol is a life-saving rescue inhaler used by tens of millions of Americans with asthma and COPD. When supply falters, the consequences are immediate and serious. Here is the complete 2026 update on the ProAir and albuterol shortage — what's changed, what's still an issue, and what you should do to protect yourself.

2026 Shortage Status: The Bottom Line

Albuterol HFA inhalers (ProAir, Ventolin, generic): Generally available at most pharmacies. Local stock-outs occur during peak respiratory season, but nationwide supply has improved.

Albuterol nebulizer solution: Still improving. On the FDA shortage list since October 2022, but new manufacturer approvals in late 2025 and early 2026 are expected to improve supply throughout the year.

ProAir HFA brand name: Discontinued by Teva in October 2022. Authorized generic albuterol HFA continues to be available.

Timeline: How We Got Here

October 2022:

The FDA placed albuterol sulfate inhalation solution (nebulizer form) on its official drug shortage list. Separately, Teva Pharmaceuticals discontinued the brand-name ProAir HFA inhaler, though authorized generic production continued. These events signaled the beginning of a long supply fragility period.

February 2023:

Akorn Pharmaceuticals, one of the largest U.S. producers of liquid albuterol, filed for bankruptcy and shut its three manufacturing plants. This left Nephron Pharmaceuticals as essentially the sole domestic manufacturer of albuterol nebulizer solution. Pediatric hospitals across the country reported critical shortages, with staff resorting to extracting medication from multiple small vials to create single doses.

2023–2024:

Supply remained tight, particularly through multiple overlapping respiratory virus seasons (flu, RSV, COVID). The Children's Hospital Association worked with compounding pharmacy STAQ Pharma to provide emergency pediatric doses. HFA inhaler stock remained relatively stable nationally, though individual pharmacy stock-outs continued to occur.

November 2025:

The FDA approved Ritedose Pharmaceuticals as a new generic albuterol manufacturer. This was a significant milestone — adding a new source to a market that had become dangerously concentrated.

March 2026:

The FDA approved Amneal Pharmaceuticals for a generic albuterol sulfate inhalation aerosol. This second new manufacturer approval adds meaningful competition to the inhaler market and should help stabilize both supply and pricing over time.

Why Local Stock-Outs Still Happen in 2026

Even with improving national supply, individual pharmacies can still run out. Here's why:

Demand surges in winter: Flu, RSV, and cold air all trigger respiratory flares. In October through March, demand for albuterol inhalers spikes dramatically.

Spring pollen season: Early and intense pollen seasons (particularly in the South and Midwest) can trigger asthma exacerbations, increasing demand.

Pharmacy ordering lag: Chain pharmacies with automated ordering systems can take days to reorder when stock runs low. Independent pharmacies may respond faster.

New manufacturer ramp-up time: FDA-approved manufacturers still need months to scale production and get product to pharmacy shelves.

What Patients Should Do Right Now

Refill before you're out. Most insurance plans allow early refills when you have roughly 25% of your supply remaining (about 50 doses on a 200-dose inhaler). Don't wait until the counter hits zero.

Know your alternatives. Ventolin HFA, Proventil HFA, and ProAir RespiClick all contain albuterol. Ask your doctor to note in your records that any of these is acceptable, so a quick phone call can get you a new prescription if needed.

Use medfinder to find availability. medfinder calls pharmacies near you to check stock. Instead of calling 10 pharmacies yourself, you get a text with results.

Talk to your doctor about preventive therapy. If you're using your rescue inhaler more than twice a week, that's a signal your asthma may not be well controlled. A daily inhaled corticosteroid can reduce how often you need your rescue inhaler, meaning you're less vulnerable to supply disruptions.

Don't ration your inhaler. Using less albuterol than needed because you're worried about running out can lead to dangerous under-treatment of an asthma attack. Always use your inhaler as prescribed during an acute episode — then work on finding a refill.

Is the ProAir Shortage Getting Resolved?

The trajectory is improving. Two new FDA-approved manufacturers entered the market in late 2025 and early 2026, and the national picture for HFA inhalers is more stable than it was in 2022–2023. The nebulizer solution shortage continues to improve. That said, local stock-outs during peak respiratory season will remain a reality for the foreseeable future. The best protection is to plan ahead, refill early, and know your options. If you're struggling to find ProAir today, check our guide on how to find ProAir in stock near you, or use medfinder to locate a pharmacy with your inhaler in stock.